SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT

HALF-YEAR FINANCIAL

QUARTERLY INFORMATION

20F

AGM

INTERNAL CONTROL

ANNUAL INFO MEMO ART

   
   
   

PERMANENT INFORMATION

2019.10.16 | 07:00 | Permanent Information Releases / General Company News

German version HTML (w) Mail

ROCHE

 Roche mit sehr gutem Verkaufswachstum in den ersten neun Monaten 2019 - Ausblick angehoben - HTML (w)

2019.10.16 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

ROCHE

 Roche reports very strong sales growth in the first nine months of 2019 - outlook raised - HTML (w)

2019.10.10 | 07:00 | Share History / Directors' Dealings

English version HTML (w) Mail

ARYZTA AG

 Director/PDMR Shareholding - HTML (w)

+ More documents (3319)

Financial transactions

2019.07.31 | 07:00 | Public offerings / Press Releases during Offer Period

English version HTML (w) Mail

ROCHE

 Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. - HTML (w)

2019.06.20 | 04:30 | Public offerings / Statement of purchases / sales

English version HTML (w) Mail

LAFARGE HOLCIM

 Lafarge S.A. announces results of its tender offer for US$600,000,000 7.125% notes due 2036 - HTML (w)

2019.03.07 | 17:35 | Public offerings / Information note / Note in response

English version HTML (w) Mail

ROCHE

 Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash - HTML (w)

2018.07.31 | 07:00 | Public offerings / Statement of purchases / sales

English version HTML (w) Mail

ROCHE

 Roche Purchases Shares in Tender Offer for FMI - HTML (w)

2018.07.02 | 17:35 | Public offerings / Information note / Note in response

English version HTML (w) Mail

ROCHE

 Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash - HTML (w)

+ More documents (38)